Effect of Clopidogrel With and Without Eptifibatide on Tumor Necrosis Factor-Alpha and C-Reactive Protein Release After Elective Stenting: Results From the CLEAR PLATELETS 1b Study
- 5 December 2006
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 48 (11) , 2186-2191
- https://doi.org/10.1016/j.jacc.2005.12.084
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of PlateletsCirculation, 2005
- GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary interventionJournal of Thrombosis and Haemostasis, 2005
- Soluble CD40 ligand is an early initiator of inflammation after coronary interventionCoronary Artery Disease, 2004
- Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary interventionThe American Journal of Cardiology, 2004
- Platelet activation in myocardial ischemic syndromesExpert Review of Cardiovascular Therapy, 2004
- Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndromeJournal of the American College of Cardiology, 2004
- A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with ClopidogrelNew England Journal of Medicine, 2004
- Clopidogrel for Coronary StentingCirculation, 2003
- Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet StimulationCirculation, 2003
- Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery DiseaseCirculation, 2000